Free Newsletter
Genetics expert leaps into gene sequencing race
Harvard Medical School professor George Church, one of the key players in the Human Genome Project and a noted expert in genetics, has set his sights on winning the $10 million prize being offered to the first team that can sequence the genomes of 100 people in 10 days at a cost of $10,000 per genome. The Archon Genomics X prize is pitting some of the leading scientists in the field in a hotly contested race to bring gene sequencing down to Main Street prices. And once that happens, researchers are quite confident that a multibillion-dollar industry will swiftly grow up around the technology as developers target a new era of personalized medicines. Tech entrepreneur Marc Hodosh was brought in to run the competition, and he's been working hard to promote it by signing up a host of celebrities like Larry King to have their genes sequenced.
To the victor go the spoils.
"If it happens in Massachusetts, it's going to help a lot of companies and individuals here in the state," Church told the Boston Globe.
- here's the article from The Boston Globe
Related Articles:
X Prize offers $10M for fast mapping. Report
$999 DNA test offers insights on disease risks. Report
Genetic test seen as big step to personalized meds. Report
FDA, Big Pharma collaborate on genetic tests. Report
Comments
Post new comment
Paid Research Reports
- The Specialty Pharma Market Outlook: Key players, new company growth models and emerging opportunities
- Investigating Clinical Trial Costs: Comparative analysis of trial cost components in key geographies
- Clinical Trial Recruitment Strategies: Optimizing patient recruitment and retention in late stage clinical trials
- Pipeline Insight: Therapeutic Cancer Vaccines - Prospect of first approval set to reinvigorate interest from major companies
- Stakeholder Opinions: Vaccines in Emerging Markets (Asia) - Opportunities in China, India, South Korea and Taiwan
- Big Pharma Performance Before, During and Beyond the Global Recession





SHARE
WITH: